BSE filing, NSE: COVIDH. Summary written from the filing by ALFA Finder's alert engine.
iSERA Lifesciences Ltd: key numbers
- Share price
- ₹143.90
- Market cap
- ₹121.0 Cr
- Revenue (annual)
- ₹1.36 Cr
- Net profit (annual)
- ₹0.26 Cr
- P/E (TTM)
- 466.5×Sector 23.6×
- Promoter holding
- 55.07%-3.56% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from iSERA Lifesciences Ltd
All →iSERA Lifesciences Q2 FY27 Results: Net Loss of ₹0.1 Cr
iSERA Lifesciences Ltd reported a net loss of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.1 Cr
iSERA Lifesciences Board Meeting Date
iSERA Lifesciences gave notice of a board meeting on November 4, 2026 to consider standalone unaudited results for the quarter and half year ended September 30, 2026. The filing also notes the trading window closure from October 1, 2026.
iSERA Lifesciences Other Announcement
iSERA Lifesciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
iSERA Lifesciences Capital Structure Change
Promoters and directors of iSERA Lifesciences acquired shares through a preferential offer valued at ₹113.98 Crore. This transaction changes the company's capital structure.
- Value
- ₹114.0 Cr
iSERA Lifesciences Capital Structure Change
Promoter Pratap Dadasaheb Deshmukh acquired 86.13 lakh shares via preferential allotment. His stake in iSERA Lifesciences shifted to 55.07% following the company's capital restructuring.
iSERA Lifesciences Capital Structure Change
iSERA Lifesciences Limited approved the allotment of 1,61,82,800 equity shares on a preferential basis. The allotment, priced at Rs. 48.20 per share, total Rs. 78.00 Crore.
- Value
- ₹78.00 Cr
Other other announcement announcements
All →Shalby Other Announcement
Shalby Limited disclosed under Regulation 30(5) that the board authorised KMP personnel for materiality determination. Mr. Tushar Shah's designation was revised after his appointment as Executive Director.
Aimtron Electronics Other Announcement
Aimtron Electronics confirmed no deviation in preferential warrant fund use for the half year ended 30 September 2026. This routine Regulation 32 statement reports no new transaction.
Asset Reconstruction Company (India) Other Announcement
Asset Reconstruction Company (India) filed its quarterly shareholding pattern for the period ended 30 September 2026. Avenue India Resurgence, a promoter, holds 60.88 percent of the company.
Jivial Industries Other Announcement
Jivial Industries Ltd filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoters hold 61.17% of equity, with the public holding the remainder.
Cubex Tubings Other Announcement
Cubex Tubings replaced its investor relations agency, ending Finportal and appointing Chanakya Advisors from 5 November 2026. No money is involved.
A F Enterprises Other Announcement
A F Enterprises applied to the ROC Delhi-II seeking extension of time to hold its 43rd AGM for FY 2025-26. The delay stems from CIRP, with Form INC-28 approval received only on 27 October 2026.